Teva CEO to present at Goldman Sachs
Analysis based on 6 articles · First reported Jun 01, 2026 · Last updated Jun 01, 2026
The market impact is generally positive for Sun Pharma Ltd. as it provides an opportunity for the company's leadership to communicate its strategy and outlook to investors, potentially increasing investor confidence. There is no direct market impact on Goldman Sachs, as it is the host of the conference.
Sun Pharma Ltd. announced that its President and CEO, Richard Francis, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026. The event will be webcast live on Sun Pharma Ltd.'s Investor Relations website, with an archived version available for 30 days. This participation allows Sun Pharma Ltd. to engage with the financial community and discuss its business transformation and future plans.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard